Advantage Accelerator

Kevin B. Clark earned his Ph.D. from the Brain and Cognitive Sciences Program at Southern Illinois University in 1999. He is an OSU alumnus and elected Full Member of Sigma Xi with an academic pedigree including eight Nobelists. Dr. Clark advances smart quantum biomolecular logic and memory systems in cell biology and for theragnostic medicine. He helped pioneer neurocybernetic prosthetic-driven targeted neuroplasticity training for human cognitive-emotional restructuring and disease/injury treatment. Dr. Clark serves/has served as Founding Member of Max Planck Alumni Entrepreneurs; Founding Organizer of MPAA Natural and Artificial Intelligence; VAGLA Consultant/Collaborator/PI; BioCoRE Member at NIH Center of Macromolecular Modeling and Bioinformatics; Senior Scientist/VP of Finance and Partnership Development at Ivy League/Oxbridge CBSA; Director at Felidae Conservation Fund; SME at UPenn PCI; Computational Neurolinguist for Google’s The Endangered Languages Project; Affiliate at NASA NAI, ARC, NfoLD, and SETI Institute; NASA GeneLab AWG Member; COV-IRT Neurology Subgroup Lead; NASEM Projects/Workshops Guest Expert; Entrepreneurship Incubation Finalist at Stanford University’s Brainstorm Innovation Lab; Berkeley Lab Molecular Foundry Community Member; Founding Member of Peace Innovation Institute at Stanford University and The Hague; Member of IEEE Brain, Life Sciences, and Quantum Initiatives; Mentor at NeuroLaunch, CyberLaunch, NeuroLex Laboratories, ConservationX Labs, NASA TRISH B-SURE, and MIT COVID19 Challenge; MIT Solve Tech Vetter; MPI for Biological Cybernetics Postdoctoral Fellow; Editor for technical journals and books; and Manager/Technical Advisor for STEAM programs sponsored by SfN, HHMI, NSF, FDA, NIH, NAIRR, NASA, sigHPC, Conrad Challenge, Portland Public Schools, UN, White House OSTP, NEON, and The Franklin Foundation for Innovation, where he was CPO and acting Chairperson, Board of Directors. He has (co)authored over 90 peer-review scientific journal articles and book chapters, generated millions of US dollars in research funding, licensed patents, and received over 70 news releases from notable multimedia sources for his collaborative science, business, and charitable activities.